Lilly discontinues semagacestat

Eli Lilly and Co. (NYSE:LLY) stopped development of Alzheimer's disease (AD) candidate

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE